ATAI Life Sciences BV (ATAI) — Cash Flow Reinvestment Rate
Latest as of June 2021:
14.68x
ATAI Life Sciences BV (ATAI) has a Cash Flow Reinvestment Rate of 14.68x as of June 2021, reinvesting $27.85 Million (capex $278.00K plus investments $-27.57 Million) from operating cash flow of $1.90 Million. Check cash flow quality index of ATAI Life Sciences BV to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
14.68x
(Capex + Investments) / Operating CF
Total Reinvested
$27.85 Million
Capex + Investments
Operating Cash Flow
$1.90 Million
USD
Capital Expenditures
$278.00K
USD
Annual Cash Flow Reinvestment Rate for ATAI Life Sciences BV (None–None)
Year-by-year capital reinvestment analysis for ATAI Life Sciences BV. For live market cap and broader valuation context, see ATAI market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow